As global markets navigate a landscape of economic uncertainty and shifting policies, Asian stocks present intriguing opportunities for investors seeking value. In this environment, identifying undervalued stocks—those trading below their intrinsic value—can be a prudent strategy to potentially capitalize on market inefficiencies.
Name | Current Price | Fair Value (Est) | Discount (Est) |
Consun Pharmaceutical Group (SEHK:1681) | HK$8.87 | HK$17.63 | 49.7% |
RACCOON HOLDINGS (TSE:3031) | ¥957.00 | ¥1890.86 | 49.4% |
Sichuan Kexin Mechanical and Electrical EquipmentLtd (SZSE:300092) | CN¥13.10 | CN¥25.69 | 49% |
TechnoPro Holdings (TSE:6028) | ¥3306.00 | ¥6593.98 | 49.9% |
S Foods (TSE:2292) | ¥2556.00 | ¥5084.09 | 49.7% |
Bide Pharmatech (SHSE:688073) | CN¥54.00 | CN¥106.91 | 49.5% |
Takara Bio (TSE:4974) | ¥866.00 | ¥1698.81 | 49% |
ALUX (KOSDAQ:A475580) | ₩11250.00 | ₩22243.70 | 49.4% |
Kinsus Interconnect Technology (TWSE:3189) | NT$93.10 | NT$182.94 | 49.1% |
Zhejiang Juhua (SHSE:600160) | CN¥24.28 | CN¥47.60 | 49% |
Click here to see the full list of 272 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.
Below we spotlight a couple of our favorites from our exclusive screener.
Overview: Smoore International Holdings Limited is an investment holding company that provides vaping technology solutions and has a market cap of HK$83.08 billion.
Operations: The company generates revenue primarily from the sale of APV and vaping devices and components, amounting to CN¥11.80 billion.
Estimated Discount To Fair Value: 13.7%
Smoore International Holdings is trading at HK$13.66, below its estimated fair value of HK$15.83, suggesting potential undervaluation based on cash flows. Earnings are forecast to grow significantly at 24.94% annually, outpacing the Hong Kong market's growth rate. However, recent financial results show a decline in net income from CNY 1,645.09 million to CNY 1,303.26 million year-over-year despite increased sales revenue to CNY 11.80 billion from CNY 11.20 billion.
Overview: Ningbo Sanxing Medical Electric Co., Ltd. manufactures and sells power distribution and utilization systems both in China and internationally, with a market cap of CN¥41.34 billion.
Operations: The company generates revenue from the manufacture and sale of power distribution and utilization systems, serving both domestic and international markets.
Estimated Discount To Fair Value: 43.1%
Ningbo Sanxing Medical Electric Ltd. is trading at CN¥29.37, significantly below its fair value estimate of CN¥51.66, highlighting potential undervaluation based on cash flows. Earnings grew by 28.5% last year and are forecast to grow 21.6% annually, though slower than the broader Chinese market's growth rate of 24.8%. Despite an unstable dividend history, revenue growth is expected to outpace the market at 21.9% per year, with analysts predicting a stock price increase of 37.8%.
Overview: Ningbo Orient Wires & Cables Co., Ltd. offers land and subsea cable solutions both in China and internationally, with a market cap of CN¥34.13 billion.
Operations: The company's revenue segments include land cable solutions generating CN¥3.45 billion and subsea cable solutions contributing CN¥2.78 billion.
Estimated Discount To Fair Value: 26.8%
Ningbo Orient Wires & Cables Ltd. trades at CN¥49.55, below its estimated fair value of CN¥67.65, suggesting undervaluation based on cash flows. Earnings are forecast to grow significantly at 30.4% annually, outpacing the Chinese market's 24.8%. Recent earnings showed a modest increase in net income to CN¥1 billion from last year, and analysts expect a stock price rise of 29.2%, despite slower revenue growth and an unstable dividend track record.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocks
Try a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.